Serious Warnings and Precautions
Hypersensitivity reactions, including dyspnea and rash, have occurred in less than 1% of patients treated with NURTEC ODT in clinical studies. Hypersensitivity reactions, including serious hypersensitivity, can occur days after administration. If a hypersensitivity reaction occurs, discontinue NURTEC ODT immediately and initiate appropriate therapy (see 2 CONTRAINDICATIONS).
Serious Warnings and Precautions
Hypersensitivity reactions, including dyspnea and rash, have occurred in less than 1% of patients treated with NURTEC ODT in clinical studies. Hypersensitivity reactions, including serious hypersensitivity, can occur days after administration. If a hypersensitivity reaction occurs, discontinue NURTEC ODT immediately and initiate appropriate therapy (see 2 CONTRAINDICATIONS).
*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product:
You may also contact the Canada Vigilance Program directly to report adverse events or product quality concerns at 1-866-234-2345 or www.healthcanada.gc.ca/medeffect.